CREACTIVE

Collaborative REsearch on ACute Traumatic brain Injury in intensiVe care medicine in Europe

 Coordinatore ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI 

 Organization address address: Via Giuseppe La Masa 19
city: MILANO
postcode: 20156

contact info
Titolo: Dr.
Nome: Guido
Cognome: Bertolini
Email: send email
Telefono: +39 0354535313
Fax: +39 0354535354

 Nazionalità Coordinatore Italy [IT]
 Totale costo 7˙032˙384 €
 EC contributo 5˙443˙350 €
 Programma FP7-HEALTH
Specific Programme "Cooperation": Health
 Code Call FP7-HEALTH-2013-INNOVATION-1
 Funding Scheme CP-IP
 Anno di inizio 2013
 Periodo (anno-mese-giorno) 2013-10-01   -   2018-09-30

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI

 Organization address address: Via Giuseppe La Masa 19
city: MILANO
postcode: 20156

contact info
Titolo: Dr.
Nome: Guido
Cognome: Bertolini
Email: send email
Telefono: +39 0354535313
Fax: +39 0354535354

IT (MILANO) coordinator 2˙386˙582.00
2    BEN-GURION UNIVERSITY OF THE NEGEV

 Organization address address: Office of the President - Main Campus
city: BEER SHEVA
postcode: 84105

contact info
Titolo: Ms.
Nome: Daphna
Cognome: Tripto
Email: send email
Telefono: +972 8 6472443
Fax: +972 8 6472930

IL (BEER SHEVA) participant 703˙680.00
3    SEMMELWEIS EGYETEM

 Organization address address: Ulloi ut 26
city: BUDAPEST
postcode: 1085

contact info
Titolo: Dr.
Nome: Akos
Cognome: Csomos
Email: send email
Telefono: +3620 8259016
Fax: +361 3251148

HU (BUDAPEST) participant 519˙726.00
4    WARSZAWSKI UNIWERSYTET MEDYCZNY

 Organization address address: UL. ZWIRKI I WIGURY 61
city: WARSZAWA
postcode: 2091

contact info
Titolo: Dr.
Nome: Malgorzata
Cognome: Mikaszewska- Sokolewicz
Email: send email
Telefono: +48 225021800
Fax: +4822 5022103

PL (WARSZAWA) participant 478˙470.00
5    PANEPISTIMIAKO GENIKO NOSOKOMEIO IRAKLEIOU

 Organization address address: VOUTES
city: IRAKLEIO
postcode: 71110

contact info
Titolo: Prof.
Nome: Dimitris
Cognome: Georgopoulos
Email: send email
Telefono: +30 2810392636

EL (IRAKLEIO) participant 374˙625.00
6    UNIVERZITETNI KLINICNI CENTER LJUBLJANA

 Organization address address: ZALOSKA CESTA 002
city: LJUBLJANA
postcode: 1000

contact info
Titolo: Mr.
Nome: Miha
Cognome: žemlja
Email: send email
Telefono: +386 1 522 21 91
Fax: +386 1 522 12 34

SI (LJUBLJANA) participant 337˙671.00
7    EDEX-EDUCATIONAL EXCELLENCE CORPORATION LIMITED

 Organization address address: MAKEDONITISAS AVENUE 46
city: NICOSIA
postcode: 1700

contact info
Titolo: Prof.
Nome: Theodoros
Cognome: Kyprianou
Email: send email
Telefono: +357 22603809
Fax: +357 22604328

CY (NICOSIA) participant 314˙645.00
8    SPLOSNA BOLNISNICA NOVO MESTO

 Organization address address: SMIHELSKA ULICA 1
city: NOVO MESTO
postcode: 8000

contact info
Titolo: Dr.
Nome: Rafael
Cognome: Kaps
Email: send email
Telefono: +386 73916530
Fax: +386 73321091

SI (NOVO MESTO) participant 256˙671.00
9    OROBIX Srl

 Organization address address: VIA LUDOVICO ANTONIO MURATORI 3
city: Bergamo
postcode: 24123

contact info
Titolo: Dr.
Nome: Luca
Cognome: Antiga
Email: send email
Telefono: 393474000000

IT (Bergamo) participant 71˙280.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

icus    severe    model    admitted    tbi    moderate    network    death    joined    prosafe    intbir    outcome    genetic    data    quality    patients    countries    prognostic   

 Obiettivo del progetto (Objective)

'Traumatic brain injury (TBI) is among the leading causes of death and disability and the main cause of death among the under-45s. Most patients with moderate to severe TBI are admitted to intensive care units (ICUs) The “PROSAFE” ICU network was recently established in 6 European countries through EU funding (PHEA 2007331), and has continued to collect high-quality data beyond the grant duration. In 2011, 225 ICUs had joined PROSAFE, recruiting a total of 73,163 patients, 2,694 of whom were admitted for TBI. Hence the network can expect to enrol 7-9,000 moderate to severe TBI patients in 4 years. The PROSAFE consortium has already focused attention on TBI and has just started collecting additional information on this condition in order to develop a prognostic model to identify centres of excellence in TBI management Aims of proposal are to consolidate the existing network in order to better describe the epidemiology of moderate-severe TBI in 7 countries (Greece has now joined the consortium); build a prognostic model based on short- and long-term outcome measures; identify most effective clinical interventions for optimally treating TBI patients, and recognize the determinants of optimal vs suboptimal performance All TBI-CDEs endorsed by InTBIR will be collected, along with other items needed to develop a sensible prognostic model, permitting the consortium to join forces with international collaborative initiatives in the field Availing of the coordinating institute’s biobank and consolidated expertise in biochemical and genetic biomarkers, the aim is to identify prognostic markers and underlying genetic factors influencing response to treatment and final outcome The PROSAFE consortium is thus in a position to guarantee superior quality data collection in 7 countries and ensure it continues beyond the life of the project. These conditions are essential if the consortium is to contribute to Europe playing a key role in the success of the InTBIR initiative'

Altri progetti dello stesso programma (FP7-HEALTH)

BIO-COMET (2011)

"Bioreactor-based, clinically oriented manufacturing of engineered tissues"

Read More  

IPACT (2014)

Image-guided pancreatic cancer therapy

Read More  

METFIZZ (2013)

Metformin for treatment of polycystic ovary syndrome in children

Read More